Latest Global Press Release Distribution & Recent News Releases

Ractigen Therapeutics Announces First Patient Dosed in Phase II Clinical Trial of RAG-17 for SOD1-ALS

NANTONG, China, Jan. 13, 2026 /PRNewswire/ -- Ractigen Therapeutics is pleased to announce that the first patient has been dosed in the Phase II clinical trial of RAG-17, an innovative siRNA therapy targeting SOD1-mutated amyotrophic lateral sclerosis (ALS). The initial dosing occurred at Second ...

2026-01-13 20:30 3250

Robotin R2 Pro Sweeps "Best of CES" Awards; Heralds a New Era in 150-Year History of Carpet Washing

LAS VEGAS, Jan. 13, 2026 /PRNewswire/ -- Following a breakout debut at CES 2026, Robotin today announced that its flagship innovation, the Robotin R2 Pro, has secured multiple top industry awards and widespread critical acclaim. By successfully bridging the gap between automated vacuuming and true...

2026-01-13 19:06 5464

aulumu Showcases High-Performance Design Philosophy at CES 2026 with G09 and M10

LAS VEGAS, Jan. 13, 2026 /PRNewswire/ -- During CES 2026, aulumu , a design brand focused on high-performance gear, drew attention by showcasing a range of its flagship products, highlighting its distinctive approach to blending functionality with visual expression. Among th...

2026-01-13 17:33 2853

aulumu Showcases High-Performance Design Philosophy at CES 2026 with G09 and M10

Delta Recognized by CDP with Double "A" Leadership Rating for Climate Change and Water Security for the Fifth Time

TAIPEI, Jan. 13, 2026 /PRNewswire/ -- Delta, a global leader in power management and smart green solutions, has been awarded double "A List" stature in the 2025 "Climate Change" and "Water Security" reports of CDP for the fifth time. This year, fewer than 1% out of 22,000+ participating companies...

2026-01-13 17:29 8520

Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in Advanced GC/GEJ

SHANGHAI, Jan. 13, 2026 /PRNewswire/ -- Immunofoco, a clinical-stage biotechnology company advancing innovative CAR-T cell therapies for solid tumors, recently announced clinical data from its Phase I/IIa study of IMC002, a VHH-based anti-CLDN18.2 CAR-T therapy, in patients with advanced gastric ...

2026-01-13 16:26 4928

BookAI Transforms Global IP Economy: Secures AIoT Partnership at CES and Opens Seed Round for Global Scalability

LAS VEGAS, Jan. 13, 2026 /PRNewswire/ -- BookAI, the pioneer in cross-language Knowledge Computing, announced today the official opening of its Seed Round financing via SAFE notes. The announcement comes immediately after a breakthrough showcase at CES 2026, where BookAI validated its B2B2C model...

2026-01-13 16:21 5016

BookAI Transforms Global IP Economy: Secures AIoT Partnership at CES and Opens Seed Round for Global Scalability

XPENG Accelerates Global Supply Chain Localization with Independent Teams in Europe and ASEAN in 2026

GUANGZHOU, China, Jan. 13, 2026 /PRNewswire/ -- XPENG is taking a decisive step in its global expansion by establishing dedicated, localized supply chain teams inEurope and ASEAN in 2026. This move deepens the company's "In Local, For Local" strategy, building on its existing overseas production,...

2026-01-13 15:48 4403